Atomic Resolution Structure of Monomorphic Aβ42 Amyloid Fibrils
Related Experiment Video
Updated: Mar 18, 2026

Atomic Scale Structural Studies of Macromolecular Assemblies by Solid-state Nuclear Magnetic Resonance Spectroscopy
Published on: September 17, 2017
Michael T Colvin1, Robert Silvers1, Qing Zhe Ni1
1Department of Chemistry and Francis Bitter Magnet Laboratory, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.
Abstract:
Amyloid-β (Aβ) is a 39-42 residue protein produced by the cleavage of the amyloid precursor protein (APP), which subsequently aggregates to form cross-β amyloid fibrils that are a hallmark of Alzheimer's disease (AD). The most prominent forms of Aβ are Aβ1-40 and Aβ1-42, which differ by two amino acids (I and A) at the C-terminus. However, Aβ42 is more neurotoxic and essential to the etiology of AD. Here, we present an atomic resolution structure of a monomorphic form of AβM01-42 amyloid fibrils derived from over 500 (13)C-(13)C, (13)C-(15)N distance and backbone angle structural constraints obtained from high field magic angle spinning NMR spectra. The structure (PDB ID: 5KK3 ) shows that the fibril core consists of a dimer of Aβ42 molecules, each containing four β-strands in a S-shaped amyloid fold, and arranged in a manner that generates two hydrophobic cores that are capped at the end of the chain by a salt bridge. The outer surface of the monomers presents hydrophilic side chains to the solvent. The interface between the monomers of the dimer shows clear contacts between M35 of one molecule and L17 and Q15 of the second. Intermolecular (13)C-(15)N constraints demonstrate that the amyloid fibrils are parallel in register. The RMSD of the backbone structure (Q15-A42) is 0.71 ± 0.12 Å and of all heavy atoms is 1.07 ± 0.08 Å. The structure provides a point of departure for the design of drugs that bind to the fibril surface and therefore interfere with secondary nucleation and for other therapeutic approaches to mitigate Aβ42 aggregation.
Insights
Researchers determined the atomic structure of amyloid-beta 42 (Aβ42) fibrils, revealing a dimeric core crucial for Alzheimer's disease pathogenesis. This structure aids in developing new Aβ42 aggregation inhibitors.
Area of Science:
- Neuroscience
- Biochemistry
- Structural Biology
Background:
- Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) fibrils.
- Aβ42 is the more neurotoxic and critical form for AD etiology.
- Understanding Aβ fibril structure is key to developing AD therapies.
Purpose of the Study:
- To determine the atomic resolution structure of Aβ42 amyloid fibrils.
- To elucidate the molecular arrangement and interactions within Aβ42 fibrils.
- To provide a structural basis for designing Aβ42 aggregation inhibitors.
Main Methods:
- High-field magic angle spinning NMR spectroscopy.
- Collection of over 500 (13)C-(13)C, (13)C-(15)N distance and backbone angle constraints.
- Atomic resolution structure determination (PDB ID: 5KK3).
Main Results:
- Revealed a fibril core composed of a dimer of Aβ42 molecules.
- Each monomer adopts an S-shaped fold with four β-strands.
- Identified specific inter-monomer contacts (M35, L17, Q15) and parallel in-register arrangement.
- Outer surfaces are hydrophilic, while two hydrophobic cores are formed within the dimer.
Conclusions:
- The determined Aβ42 fibril structure offers insights into its aggregation mechanism.
- The structure facilitates the design of drugs targeting fibril surfaces to inhibit secondary nucleation.
- This work provides a foundation for novel therapeutic strategies against Aβ42 aggregation in Alzheimer's disease.
More Related Videos
06:27Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
12:58Characterizing Individual Protein Aggregates by Infrared Nanospectroscopy and Atomic Force Microscopy
Published on: September 12, 2019
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...
Protein Folding